Alpha 1 antitrypsin. Medical search

Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.

Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.

Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.

A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36.

Glycoprotein found in alpha(1)-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily.

A pathological accumulation of air in tissues or organs.

Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds.

An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.

One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation.

Hypoxia-inducible factor 1, alpha subunit is a basic helix-loop-helix transcription factor that is regulated by OXYGEN availability and is targeted for degradation by VHL TUMOR SUPPRESSOR PROTEIN.

A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES, and some serpins occur in plants where their function is not known.

Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES.

The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.

The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.

A member of the NICOTINIC ACETYLCHOLINE RECEPTOR subfamily of the LIGAND-GATED ION CHANNEL family. It consists entirely of pentameric a7 subunits expressed in the CNS, autonomic nervous system, vascular system, lymphocytes and spleen.

Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.

Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point.

A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.

Cell surface receptor for LAMININ, epiligrin, FIBRONECTINS, entactin, and COLLAGEN. Integrin alpha3beta1 is the major integrin present in EPITHELIAL CELLS, where it plays a role in the assembly of BASEMENT MEMBRANE as well as in cell migration, and may regulate the functions of other integrins. Two alternatively spliced isoforms of the alpha subunit (INTEGRIN ALPHA3), are differentially expressed in different cell types.

An integrin alpha subunit that is unique in that it does not contain an I domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane as in other integrin alpha subunits.

An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.

Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.

Proteins prepared by recombinant DNA technology.

An integrin found in FIBROBLASTS; PLATELETS; MONOCYTES, and LYMPHOCYTES. Integrin alpha5beta1 is the classical receptor for FIBRONECTIN, but it also functions as a receptor for LAMININ and several other EXTRACELLULAR MATRIX PROTEINS.

The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.

Integrin alpha4beta1 is a FIBRONECTIN and VCAM-1 receptor present on LYMPHOCYTES; MONOCYTES; EOSINOPHILS; NK CELLS and thymocytes. It is involved in both cell-cell and cell- EXTRACELLULAR MATRIX adhesion and plays a role in INFLAMMATION, hematopoietic cell homing and immune function, and has been implicated in skeletal MYOGENESIS; NEURAL CREST migration and proliferation, lymphocyte maturation and morphogenesis of the PLACENTA and HEART.

An interleukin-1 subtype that occurs as a membrane-bound pro-protein form that is cleaved by proteases to form a secreted mature form. Unlike INTERLEUKIN-1BETA both membrane-bound and secreted forms of interleukin-1alpha are biologically active.

Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.

Pathological processes of the LIVER.

The rate dynamics in chemical or physical systems.

An integrin found on fibroblasts, platelets, endothelial and epithelial cells, and lymphocytes where it functions as a receptor for COLLAGEN and LAMININ. Although originally referred to as the collagen receptor, it is one of several receptors for collagen. Ligand binding to integrin alpha2beta1 triggers a cascade of intracellular signaling, including activation of p38 MAP kinase.

The parts of a macromolecule that directly participate in its specific combination with another molecule.

Hepatocyte nuclear factor 1-alpha is a transcription factor found in the LIVER; PANCREAS; and KIDNEY that regulates HOMEOSTASIS of GLUCOSE.

The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.

A subclass of alpha-adrenergic receptors that mediate contraction of SMOOTH MUSCLE in a variety of tissues such as ARTERIOLES; VEINS; and the UTERUS. They are usually found on postsynaptic membranes and signal through GQ-G11 G-PROTEINS.

Plasma glycoproteins that form a stable complex with hemoglobin to aid the recycling of heme iron. They are encoded in man by a gene on the short arm of chromosome 16.

The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).

This integrin alpha subunit combines with INTEGRIN BETA1 to form a receptor (INTEGRIN ALPHA5BETA1) that binds FIBRONECTIN and LAMININ. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds.

Integrin alpha1beta1 functions as a receptor for LAMININ and COLLAGEN. It is widely expressed during development, but in the adult is the predominant laminin receptor (RECEPTORS, LAMININ) in mature SMOOTH MUSCLE CELLS, where it is important for maintenance of the differentiated phenotype of these cells. Integrin alpha1beta1 is also found in LYMPHOCYTES and microvascular endothelial cells, and may play a role in angiogenesis. In SCHWANN CELLS and neural crest cells, it is involved in cell migration. Integrin alpha1beta1 is also known as VLA-1 and CD49a-CD29.

A subclass of alpha-adrenergic receptors found on both presynaptic and postsynaptic membranes where they signal through Gi-Go G-PROTEINS. While postsynaptic alpha-2 receptors play a traditional role in mediating the effects of ADRENERGIC AGONISTS, the subset of alpha-2 receptors found on presynaptic membranes signal the feedback inhibition of NEUROTRANSMITTER release.

A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side.

A cell surface receptor mediating cell adhesion to the EXTRACELLULAR MATRIX and to other cells via binding to LAMININ. It is involved in cell migration, embryonic development, leukocyte activation and tumor cell invasiveness. Integrin alpha6beta1 is the major laminin receptor on PLATELETS; LEUKOCYTES; and many EPITHELIAL CELLS, and ligand binding may activate a number of signal transduction pathways. Alternative splicing of the cytoplasmic domain of the alpha6 subunit (INTEGRIN ALPHA6) results in the formation of A and B isoforms of the heterodimer, which are expressed in a tissue-specific manner.

Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Serum globulins with high molecular weight. (Dorland, 28th ed)

Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.

The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.

This intrgrin is a key component of HEMIDESMOSOMES and is required for their formation and maintenance in epithelial cells. Integrin alpha6beta4 is also found on thymocytes, fibroblasts, and Schwann cells, where it functions as a laminin receptor (RECEPTORS, LAMININ) and is involved in wound healing, cell migration, and tumor invasiveness.

The alpha subunits of integrin heterodimers (INTEGRINS), which mediate ligand specificity. There are approximately 18 different alpha chains, exhibiting great sequence diversity; several chains are also spliced into alternative isoforms. They possess a long extracellular portion (1200 amino acids) containing a MIDAS (metal ion-dependent adhesion site) motif, and seven 60-amino acid tandem repeats, the last 4 of which form EF HAND MOTIFS. The intracellular portion is short with the exception of INTEGRIN ALPHA4.

A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed)

A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors(RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.

Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.

Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.

An integrin alpha subunit that binds COLLAGEN and LAMININ though its I domain. It combines with INTEGRIN BETA1 to form the heterodimer INTEGRIN ALPHA1BETA1.

A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).

Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.

A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.

An individual having different alleles at one or more loci regarding a specific character.

An individual in which both alleles at a given locus are identical.

Brain waves characterized by a relatively high voltage or amplitude and a frequency of 8-13 Hz. They constitute the majority of waves recorded by EEG registering the activity of the parietal and occipital lobes when the individual is awake, but relaxed with the eyes closed.

A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and is able to inhibit activated PROTEIN C; THROMBIN; KALLIKREIN; and other SERINE ENDOPEPTIDASES.

Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.

A serine endopeptidase found primarily in the EXTRACELLULAR MATRIX. It has specificity for cleavage of a variety of substrates including PRORENIN, pro-membrane type-1 matrix metalloproteinase, and NEURAL CELL ADHESION MOLECULE L1.

The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.

A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.

An integrin alpha subunit that occurs as alternatively spliced isoforms. The isoforms are differentially expressed in specific cell types and at specific developmental stages. Integrin alpha3 combines with INTEGRIN BETA1 to form INTEGRIN ALPHA3BETA1 which is a heterodimer found primarily in epithelial cells.

A proprotein convertase with specificity for the proproteins of PROALBUMIN; COMPLEMENT 3C; and VON WILLEBRAND FACTOR. It has specificity for cleavage near paired ARGININE residues that are separated by two amino acids.

Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.

The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. (1/1525)

The disulfide-bonded loop of chromogranin B (CgB), a regulated secretory protein with widespread distribution in neuroendocrine cells, is known to be essential for the sorting of CgB from the trans-Golgi network (TGN) to immature secretory granules. Here we show that this loop, when fused to the constitutively secreted protein alpha1-antitrypsin (AT), is sufficient to direct the fusion protein to secretory granules. Importantly, the sorting efficiency of the AT reporter protein bearing two loops (E2/3-AT-E2/3) is much higher compared with that of AT with a single disulfide-bonded loop. In contrast to endogenous CgB, E2/3-AT-E2/3 does not undergo Ca2+/pH-dependent aggregation in the TGN. Furthermore, the disulfide-bonded loop of CgB mediates membrane binding in the TGN and does so with 5-fold higher efficiency if two loops are present on the reporter protein. The latter finding supports the concept that under physiological conditions, aggregates of CgB are the sorted units of cargo which have multiple loops on their surface leading to high membrane binding and sorting efficiency of CgB in the TGN. (+info)

Identification of DNA polymorphisms associated with the V type alpha1-antitrypsin gene. (2/1525)

alpha1-Antitrypsin (alpha1-AT) is a highly polymorphic protein. The V allele of alpha1-AT has been shown to be associated with focal glomerulosclerosis (FGS) in Negroid and mixed race South African patients. To identify mutations and polymorphisms in the gene for the V allele of alpha1-AT in five South African patients with FGS nephrotic syndrome DNA sequence analysis and restriction fragment length polymorphisms of the coding exons were carried out. Four of the patients were heterozygous for the BstEII RFLP in exon III [M1(Val213)(Ala213)] and one patient was a M1(Ala213) homozygote. The mutation for the V allele was identified in exon II as Gly-148 (GGG)-->Arg (AGG) and in all patients was associated with a silent mutation at position 158 (AAC-->AAT). The patient who was homozygous for (Ala213) also had a silent mutation at position 256 in exon III (GAT-->GAC) which was not present in any of the other four patients. Although the V allele of alpha1-AT is not associated with severe plasma deficiency, it may be in linkage disequilibrium with other genes on chromosome 14 that predispose to FGS. Furthermore, the associated silent mutation at position 158 and the Ala213 polymorphism are of interest, as these could represent an evolutionary intermediate between the M1(Ala213) and M1(Val213) subtypes. (+info)

The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. (3/1525)

Alpha1 Protease inhibitor (alpha1PI) modulates serine protease activity in the lung. Reactive oxygen species inactivate alpha1PI, and this process has been implicated in the pathogenesis of a variety of forms of lung injury. An imbalance of protease-antiprotease activity is also detected in the airways of patients with cystic fibrosis-associated lung disease who are infected with Pseudomonas aeruginosa. P. aeruginosa secretes pyocyanin, which, through its ability to redox cycle, induces cells to generate reactive oxygen species. We tested the hypothesis that redox cycling of pyocyanin could lead to inactivation of alpha1PI. When alpha1PI was exposed to NADH and pyocyanin, a combination that results in superoxide production, alpha1PI lost its ability to form an inhibitory complex with both porcine pancreatic elastase (PPE) and trypsin. Similarly, addition of pyocyanin to cultures of human airway epithelial cells to which alpha1PI was also added resulted in a loss of the ability of alpha1PI to form a complex with PPE or trypsin. Neither superoxide dismutase, catalase, nor dimethylthiourea nor depletion of the media of O2 to prevent formation of reactive oxygen species blocked pyocyanin-mediated inactivation of alpha1PI. These data raise the possibility that a direct interaction between reduced pyocyanin and alpha1PI is involved in the process. Consistent with this possibility, pretreatment of alpha1PI with the reducing agent beta-mercaptoethanol also inhibited binding of trypsin to alpha1PI. These data suggest that pyocyanin could contribute to lung injury in the P. aeruginosa-infected airway of cystic fibrosis patients by decreasing the ability of alpha1PI to control the local activity of serine proteases. (+info)

Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. (4/1525)

The role of conformation-based quality control in the early secretory pathway is to eliminate misfolded polypeptides and unassembled multimeric protein complexes from the endoplasmic reticulum, ensuring the deployment of only functional molecules to distal sites. The intracellular fate of terminally misfolded human alpha1-antitrypsin was examined in hepatoma cells to identify the functional role of asparagine-linked oligosaccharide modification in the selection of glycoproteins for degradation by the cytosolic proteasome. Proteasomal degradation required physical interaction with the molecular chaperone calnexin. Altered sedimentation of intracellular complexes following treatment with the specific proteasome inhibitor lactacystin, and in combination with mannosidase inhibition, revealed that the removal of mannose from attached oligosaccharides abrogates the release of misfolded alpha1-antitrypsin from calnexin prior to proteasomal degradation. Intracellular turnover was arrested with kifunensine, implicating the participation of endoplasmic reticulum mannosidase I in the disposal process. Accelerated degradation occurred in a mannosidase-independent manner and was arrested by lactacystin, in response to the posttranslational inhibition of glucosidase II, demonstrating that the attenuated removal of glucose from attached oligosaccharides functions as the underlying rate-limiting step in the proteasome-mediated pathway. A model is proposed in which the removal of mannose from multiple attached oligosaccharides directs calnexin in the selection of misfolded alpha1-antitrypsin for degradation by the proteasome. (+info)

Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. (5/1525)

Matrix metalloproteinases (MMPs) are believed to contribute to the complex process of cancer progression. They also exhibit an alpha1-proteinase inhibitor (alphaPI)-degrading activity generating a carboxyl-terminal fragment of approximately 5 kd (alphaPI-C). This study reports that overexpression of alphaPI-C in S2-020, a cloned subline derived from the human pancreas adenocarcinoma cell line SUIT-2, potentiates the growth capability of the cells in nude mice. After stable transfection of a vector containing a chimeric cDNA encoding a signal peptide sequence of tissue inhibitor of metalloproteinase-1 followed by cDNA for alphaPI-C into S2-020 cells, three clones that stably secrete alphaPI-C were obtained. The ectopic expression of alphaPI-C did not alter in vitro cellular growth. However, subcutaneous injection of the alphaPI-C-secreting clones resulted in tumors that were 1.5 to 3-fold larger than those of control clones with an increased tendency to invasiveness and lymph node metastasis. These effects could be a result of modulation of natural killer (NK) cell-mediated control of tumor growth in nude mice, as the growth advantage of alphaPI-C-secreting clones was not observed in NK-depleted mice, and alphaPI-C-secreting clones showed decreased NK sensitivity in vitro. In addition, production of alphaPI and generation of the cleaved form of alphaPI by MMP were observed in various human tumor cell lines and in a highly metastatic subline of SUIT-2 in vitro. These results provide experimental evidence that the alphaPI-degrading activity of MMPs may play a role in tumor progression not only via the inactivation of alphaPI but also via the generation of alphaPI-C. (+info)

Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. (6/1525)

Various treatment regimens and difficulties with research design are encountered with cystic fibrosis (CF) because no standard diagnostic criteria exist for defining acute respiratory exacerbations. This study evaluated the role of serial monitoring of concentrations of selected cytokines and inflammatory mediators in serum and sputum as predictors of respiratory exacerbation, as useful outcome measures for CF, and to guide therapy. Interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha), neutrophil elastase-alpha-1-protease inhibitor complex (NE complex), protein, and alpha-1-protease inhibitor (alpha-1-PI) were measured in serum and sputum collected from CF patients during respiratory exacerbations and periods of well-being. Levels of NE complex, protein, and alpha-1-PI in sputum rose during respiratory exacerbations and fell after institution of antibiotic therapy (P = 0.078, 0.001, and 0.002, respectively). Mean (+/- standard error of the mean) levels of IL-8 and TNF-alpha were extremely high in sputum (13,780 +/- 916 and 249.4 +/- 23.5 ng/liter, respectively) but did not change significantly with clinical deterioration of the patient (P > 0.23). IL-8 and TNF-alpha were generally undetectable in serum, and therefore these measures were unhelpful. Drop in forced expiratory volume in 1 s was the only clinical or laboratory parameter that was close to being a determinant of respiratory exacerbation (P = 0.055). This study provides evidence of intense immunological activity occurring continually within the lungs of adult CF patients. Measurement of cytokines and inflammatory mediators in CF sputum is not helpful for identifying acute respiratory exacerbations. (+info)

Probing the unfolding pathway of alpha1-antitrypsin. (7/1525)

Protein misfolding plays a role in the pathogenesis of many diseases. alpha1-Antitrypsin misfolding leads to the accumulation of long chain polymers within the hepatocyte, reducing its plasma concentration and predisposing the patient to emphysema and liver disease. In order to understand the misfolding process, it is necessary to examine the folding of alpha1-antitrypsin through the different structures involved in this process. In this study we have used a novel technique in which unique cysteine residues were introduced at various positions into alpha1-antitrypsin and fluorescently labeled with N, N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)ethylenediamine. The fluorescence properties of each protein were studied in the native state and as a function of guanidine hydrochloride-mediated unfolding. The studies found that alpha1-antitrypsin unfolded through a series of intermediate structures. From the position of the fluorescence probes, the fluorescence quenching data, and the molecular modeling, we show that unfolding of alpha1-antitrypsin occurs via disruption of the A and C beta-sheets followed by the B beta-sheet. The implications of these data on both alpha1-antitrypsin function and polymerization are discussed. (+info)

A kinetic mechanism for the polymerization of alpha1-antitrypsin. (8/1525)

The mutation in the Z deficiency variant of alpha1-antitrypsin perturbs the structure of the protein to allow a unique intermolecular linkage. These loop-sheet polymers are retained within the endoplasmic reticulum of hepatocytes to form inclusions that are associated with neonatal hepatitis, juvenile cirrhosis, and hepatocellular carcinoma. The process of polymer formation has been investigated here by intrinsic tryptophan fluorescence, fluorescence polarization, circular dichroic spectra and extrinsic fluorescence with 8-anilino-1-naphthalenesulfonic acid and tetramethylrhodamine-5-iodoacetamide. These biophysical techniques have demonstrated that alpha1-antitrypsin polymerization is a two-stage process and have allowed the calculation of rates for both of these steps. The initial fast phase is unimolecular and likely to represent temperature-induced protein unfolding, while the slow phase is bimolecular and associated with loop-sheet interaction and polymer formation. The naturally occurring Z, S, and I variants and recombinant site-directed reactive loop and shutter domain mutants of alpha1-antitrypsin were used to demonstrate the close association between protein stability and rate of alpha1-antitrypsin polymerization. Taken together, these data allow us to propose a kinetic mechanism for alpha1-antitrypsin polymer formation that involves the generation of an unstable intermediate, which can form polymers or generate latent protein. (+info)

Owen MC, Brennan SO, Lewis JH, Carrell RW (September 1983). "Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin ... DeMeo DL, Silverman EK (March 2004). "Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: ... The alpha region can be further divided into two sub-regions, termed "1" and "2". Alpha-1 antitrypsin is the main protein of ... Alpha-1 antitrypsin or α1-antitrypsin (A1AT, α1AT, A1A, or AAT) is a protein belonging to the serpin superfamily. It is encoded ...

https://en.wikipedia.org/wiki/Alpha-1_antitrypsin

... (A1AD or AATD) is a genetic disorder that may result in lung disease or liver disease. Onset of ... Alpha-1 antitrypsin levels in the blood depend on the genotype. Some mutant forms fail to fold properly and are, thus, targeted ... In newborns, alpha-1 antitrypsin deficiency can result in early onset jaundice followed by prolonged jaundice. Between 3% and 5 ... A1AD is due to a mutation in the SERPINA1 gene that results in not enough alpha-1 antitrypsin (A1AT). Risk factors for lung ...

https://en.wikipedia.org/wiki/Alpha-1_antitrypsin_deficiency

"Alpha-1 Antitrypsin Deficiency". MedlinePlus. Leslie, Nancy; Tinkle, Brad T. (1993). "Pompe Disease". In Pagon, Roberta A.; ... Liver damage is also a clinical feature of alpha 1-antitrypsin deficiency and glycogen storage disease type II. In ... 327 (1-2): 26-47. doi:10.1016/j.canlet.2012.01.016. PMID 22293091. Nishida N, Kudo M (2013). "Oxidative stress and epigenetic ... 25 (1): 142-63. doi:10.1128/CMR.00018-11. PMC 3255968. PMID 22232374. Suk KT, Kim MY, Baik SK (September 2014). "Alcoholic ...

https://en.wikipedia.org/wiki/Liver_disease

... alpha 1-antitrypsin deficiency; 2% replacing previously transplanted lungs that have since failed; 24% other causes, including ... 1 May 2008. Archived from the original on 5 June 2010. Retrieved 28 July 2010. Wijesinha M, Hirshon JM, Terrin M, Magder L, ... 109 (1): 49-59. doi:10.1016/S0022-5223(95)70419-1. PMID 7815807. Merck Manual 18th ed. p. 1377 "2008 OPTN/SRTR Annual Report". ... these median survival estimates were conditional on surviving 1 year post-transplant. Sarah Murnaghan lung transplant ...

https://en.wikipedia.org/wiki/Lung_transplantation

... is also used to identify alpha-1 antitrypsin globules in hepatocytes, which is a characteristic finding of ... Patel, D; Teckman, JH (November 2018). "Alpha-1-Antitrypsin Deficiency Liver Disease". Clinics in Liver Disease. 22 (4): 643- ... alpha-1 antitrypsin deficiency. PAS diastase stain is also used in diagnosing Whipple's disease, as the foamy macrophages that ...

https://en.wikipedia.org/wiki/PAS_diastase_stain

Individuals with alpha 1-antitrypsin deficiency have been found to be particularly susceptible to bronchiectasis, due to the ... "Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency". American Journal of Respiratory and Critical Care ... It is important to establish whether an underlying modifiable cause, such as immunoglobulin deficiency or alpha-1 antitrypsin ... Shin MS, Ho KJ (1993). "Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence?". Chest. 104 (5): ...

https://en.wikipedia.org/wiki/Bronchiectasis

To give α1 antitrypsin to someone with alpha 1-antitrypsin deficiency. Wright, BM; Eiland EH, 3rd; Lorenz, R (March 2013). " ... Campos, MA; Lascano, J (October 2014). "α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy". ...

https://en.wikipedia.org/wiki/Augmentation_(pharmacology)

One of the outcomes of this research was the use of alpha-amylase gene promoters to express human proteins in transgenic rice ... Sequence-specific interactions of a nuclear protein factor with the promoter of a rice gene for alpha-amylase, RAamy3D.. Nucl. ... Metabolic regulation of rice alpha-amylase and sucrose synthase genes in planta. The Plant Journal, 2(4):517-523. Huang, N., ... Organization, structure and expression of the rice alpha-amylase multigene family. In, Rice Genetics II. Manila, pp. 417-429. ...

https://en.wikipedia.org/wiki/Raymond_L._Rodriguez

Zemaira (Alpha-1 antitrypsin), for chronic augmentation, now owned by CSL Behring. Mucosolvan Medicine for Cough - Rheumatology ... Thymoglobulin, for hemophilia A. Zemaira (Alpha-1 antitrypsin), for chronic augmentation, Now owned by CSL Behring. - ... 1 December 2021. "Sanofi in $1 bln deal to buy U.S.-based Amunix Pharma , Reuters". Reuters. 21 December 2021. Joyce Teo (20 ... 25 (1): 22-27. Sanofi-Synthélabo Form 20F for the Fiscal Year ended 31 December 2002 Denis Cosnard for Les Echos. 11 December ...

https://en.wikipedia.org/wiki/Sanofi

Hayes VM, Gardiner-Garden M (Oct 2003). "Are polymorphic markers within the alpha-1-antitrypsin gene associated with risk of ... 2004). "Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene". Arterioscler. Thromb. Vasc ... 2001). "In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL". Arterioscler. Thromb. Vasc. Biol. 21 (11): 1801-8 ... AMY-1-associating protein expressed in testis 1 is a protein that in humans is encoded by the MAATS1 (formerly known as C3orf15 ...

https://en.wikipedia.org/wiki/MAATS1

Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2 is a protein that in humans is encoded by ... antitrypsin like gene, it was discovered that SERPINA2 did not have any promoter but did contain substantial homology to ... Rollini P, Fournier RE (December 1997). "Molecular linkage of the human alpha 1-antitrypsin and corticosteroid-binding globulin ... "Entrez Gene: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2". Retrieved 2017-09-21. Hofker ...

https://en.wikipedia.org/wiki/SERPINA2

If stool alpha-1 antitrypsin is elevated, this suggests excessive gastrointestinal protein loss. Treatment of hypoalbuminemia ... If protein-losing enteropathy is suspected based on clinical suspicion, an alpha-1 antitrypsin test can be performed. ... 10 (1): 88. doi:10.3390/nu10010088. ISSN 2072-6643. PMC 5793316. PMID 29342898. Kooman, Jeroen P.; van der Sande, Frank M. ( ... 47 (1-3): 223-229. doi:10.1159/000494583. ISSN 1421-9735. PMC 6492508. PMID 30517920. Dekker, Marijke J. E.; van der Sande, ...

https://en.wikipedia.org/wiki/Hypoalbuminemia

Much of Yu's work has focused on unlocking the structure and folding of the protein alpha-1 antitrypsin, which is a serpin ... "The Z type variation of human α1-antitrypsin causes a protein folding defect". Nature Structural & Molecular Biology. 2 (5): ... She has also patented the alpha-1 antitrypsin mutein with a disulfide bond and the method for preparing it along with her ... "Single amino acid substitutions of alpha 1-antitrypsin that confer enhancement in thermal stability". The Journal of Biological ...

https://en.wikipedia.org/wiki/Yu_Myeong-Hee

... comparison of complementary DNA encoding Hp alpha 1S and Hp alpha 2FS". Nucleic Acids Res. 12 (11): 4531-8. doi:10.1093/nar/ ... "Characterization of human haptoglobin cDNAs coding for alpha 2FS beta and alpha 1S beta variants". FEBS Lett. 168 (1): 103-7. ... The HP gene encodes a preproprotein that is processed to yield both alpha and beta chains, which subsequently combines as a ... van der Straten A, Falque JC, Loriau R, Bollen A, Cabezón T (1986). "Expression of cloned human haptoglobin and alpha 1- ...

https://en.wikipedia.org/wiki/Haptoglobin

"Entrez Gene: SERPINA4 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4". Wang G, Zou J, Yu X ... 247B: 1-8. doi:10.1007/978-1-4615-9546-5_1. ISBN 978-1-4615-9548-9. PMID 2558505. Chen LM, Song Q, Chao L, Chao J (1995). " ... 1544 (1-2): 113-22. doi:10.1016/S0167-4838(00)00209-0. PMID 11341921. Miao RQ, Agata J, Chao L, Chao J (2002). "Kallistatin is ... 382 (1): 15-21. doi:10.1515/BC.2001.003. PMID 11258665. S2CID 33204682. Zhou GX, Chao L, Chao J (1993). "Kallistatin: a novel ...

https://en.wikipedia.org/wiki/Kallistatin

It is an alpha-globulin. This gene encodes an alpha-globulin protein with corticosteroid-binding properties. This is the major ... antitrypsin), member 6". E. Edward Bittar; Neville Bittar (1997). Molecular and Cellular Endocrinology. Elsevier. p. 238. ISBN ... "Entrez Gene: SERPINA6 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, ... allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency". Am J Hum Genet. 55 (1): 126-33. PMC ...

https://en.wikipedia.org/wiki/Transcortin

Alpha-1 antitrypsin deficiency (A1AD) leads to uninhibited destruction of elastic fibre by elastase; the main result is ... Elastase is inhibited by the acute-phase protein α1-antitrypsin (A1AT), which binds almost irreversibly to the active site of ... break down cytokines and alpha proteinase inhibitor, cleave immunoglobulin A and G (IgA, IgG), and cleave both C3bi, a ...

https://en.wikipedia.org/wiki/Elastase

Lungs: Emphysema due to alpha-1 antitrypsin deficiency is a slowly progressive pulmonary disease. Kidneys: Goodpasture's ... Pancreas: Type 1 diabetes mellitus involves rapidly progressive loss of insulin secretory capacity compared to type 2 diabetes ...

https://en.wikipedia.org/wiki/Progressive_disease

Alpha 1-antitrypsin deficiency was documented in one case, interferon-alpha therapy in another case. Similar cases of ... Shaaban, H.; Slim, J.; Choo, H. (2012). "Idiopathic granulomatous mastitis as a complication of interferon-alpha therapy". ... 11 (1): 73. doi:10.1111/j.1075-122X.2005.21404.x. PMID 15647084. S2CID 46709562. Goldberg, J.; Baute, L.; Storey, L.; Park, P ... 15 (1): 111-118. doi:10.4048/jbc.2012.15.1.111. PMC 3318162. PMID 22493637. Schelfout, K.; Tjalma, W. A.; Cooremans, I. D.; ...

https://en.wikipedia.org/wiki/Granulomatous_mastitis

The active ingredient in the drug is the protein alpha-1 antitrypsin, for patients with a genetic deficiency in that protein. ... Kamada's flagship product is Glassia, approved by the FDA to treat alpha 1-antitrypsin deficiency. ... and Baxter Enter into a Strategic Agreement for the Distribution and Manufacture of Intravenous Liquid AAT to Treat Alpha-1 ... Antitrypsin Deficiency in the US". www.businesswire.com. 2010-08-24. Retrieved 2019-05-15. גביזון, יורם (2011-08-30). "קמהדע ...

https://en.wikipedia.org/wiki/Kamada_(company)

Brooke McCarter, 52, American model and actor (The Lost Boys, Thrashin', Wired), alpha 1-antitrypsin deficiency. Freda Meissner ... 1. Lockheed Martin Aeronautics Company. December 22, 2015. Retrieved August 16, 2021. "Jewish anti-Nazi Partisan Andreja Preger ... Glenroe creator Wesley Burrowes dies, aged 85 Archived January 1, 2016, at the Wayback Machine McShane, Larry. "Natalie Cole ...

https://en.wikipedia.org/wiki/Deaths_in_December_2015

Radicals produced by cigarette smoke are implicated in inactivation of alpha 1-antitrypsin in the lung. This process promotes ... Radicals are either (1) formed from spin-paired molecules or (2) from other radicals. Radicals are formed from spin-paired ... 1 below). These reactions give the chlorine radical, Cl•, which catalyzes the conversion of ozone to O2, thus facilitating ... 1 (12): 970-81. doi:10.1039/b206338g. PMID 12661594. Njie-Mbye, Ya Fatou; Kulkarni-Chitnis, Madhura; Opere, Catherine A.; ...

https://en.wikipedia.org/wiki/Radical_(chemistry)

Human alpha-1-antitrypsin is another protein that is used in treating humans with this deficiency. Another area is in creating ... "Antibody response to aerosolized transgenic human alpha1-antitrypsin". The New England Journal of Medicine. 352 (19): 2030-1. ... 16 (1): e19. doi:10.1002/cpet.19. Lu JW, Ho YJ, Ciou SC, Gong Z (September 2017). "Innovative Disease Model: Zebrafish as an In ... 9 (1): 59. doi:10.3390/su9010059. Simmons GS, McKemey AR, Morrison NI, O'Connell S, Tabashnik BE, Claus J, Fu G, Tang G, Sledge ...

https://en.wikipedia.org/wiki/Genetically_modified_animal

Other possibilities that have been advanced have included cystic fibrosis, cirrhosis, and alpha 1-antitrypsin deficiency. A ... 1. The anodyne thanks he received from Maria proved to be the last letter he was to have from her. Chopin placed the letters he ... 1. This was the first of his works to be commercially published and earned him his first mention in the foreign press, when the ... 1. Samson 2001, §2, para. 3. The journal is now in the National Library of Poland. Walker 2018, p. 202. Zofia Helman, Hanna ...

https://en.wikipedia.org/wiki/Frédéric_Chopin

July 1988). "Linkage between the variegate porphyria (VP) and the alpha-1-antitrypsin (PI) genes on human chromosome 14". Hum. ... ISBN 978-1-4051-3400-2. Mustajoki, P. (1980). "Variegate porphyria. Twelve years' experience in Finland". The Quarterly Journal ... In Finland, the prevalence is approximately 1 in 75,000. It is also found in Argentina, Sweden, and Australia. James, William D ... ISBN 978-1-4160-2999-1. "porphyria variegata" at Dorland's Medical Dictionary Frank J, Christiano AM (1998). "Variegate ...

https://en.wikipedia.org/wiki/Variegate_porphyria

The propeptide region has an open-sandwich antiparallel-alpha/antiparallel-beta fold, with two alpha-helices and four beta- ... It forms an alpha-helical domain that runs through the substrate-binding site, preventing access. Removal of this region by ... Aprotinin Bestatin Calpain inhibitor I and II Chymostatin E-64 Leupeptin (N-acetyl-L-leucyl-L-leucyl-L-argininal) alpha-2- ... In medicine, protease inhibitor is often used interchangeably with alpha 1-antitrypsin (A1AT, which is abbreviated PI for this ...

https://en.wikipedia.org/wiki/Protease_inhibitor_(biology)

Hu C, Perlmutter DH (2002). "Cell-specific involvement of HNF-1beta in alpha(1)-antitrypsin gene expression in human ... 68 (1): 219-24. doi:10.1086/316945. PMC 1234916. PMID 11085914. Ek J, Grarup N, Urhammer SA, Gaede PH, Drivsholm T, Borch- ... 45 (1): 153-4. doi:10.1007/s001250200019. PMID 11845237. Yoshiuchi I, Yamagata K, Zhu Q, Tamada I, Takahashi Y, Onigata K, ... 8 (1): 165-7. doi:10.1016/0888-7543(90)90239-Q. PMID 2081590. Bach I, Yaniv M (1993). "More potent transcriptional activators ...

https://en.wikipedia.org/wiki/HNF1B

Certain diseases, such as hemochromatosis and alpha 1-antitrypsin deficiency, markedly increase the risk of developing HCC. ... alpha-fetoprotein and des-gamma carboxyprothrombin levels), evaluation requires imaging of the liver by CT or MRI scans. ... Alpha 1-antitrypsin deficiency Wilson's disease (controversial; while some theorise the risk increases, case studies are rare ... and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review". The American Journal of Gastroenterology. ...

https://en.wikipedia.org/wiki/Hepatocellular_carcinoma

Alpha 1-antitrypsin comprised 50% of the total protein in Tracy's milk, a remarkably high level maintained after lactation. ... was a transgenically modified sheep created by scientists at Scotland's Roslin Institute to produce the human protein alpha 1- ... antitrypsin, a substance regarded in the 1990s as a potential pharmaceutical for the treatments of cystic fibrosis and ...

https://en.wikipedia.org/wiki/Tracy_(sheep)

The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and ... Staff (1 April 2015). "Novartis Sells RNAi R&D Portfolio to Arrowhead in $35M Agreement". News: Industry Watch. Genetic ...

https://en.wikipedia.org/wiki/Arrowhead_Pharmaceuticals

Other conditions associated with lung bullae are: Alpha 1-antitrypsin deficiency Marfan syndrome Ehlers-Danlos syndromes ... A bleb has a wall thickness of less than 1 mm. By radiology definition, it is up to 1 cm in total size. By pathology definition ... A minimum wall thickness of 1 mm has been suggested, but thin-walled pockets may be included in the definition as well. A ... 9 (1): 73-86. doi:10.1007/s13244-017-0581-2. ISSN 1869-4101. PMC 5825309. PMID 29143191. Gadkowski, L. Beth; Stout, Jason E. (9 ...

https://en.wikipedia.org/wiki/Focal_lung_pneumatosis

... involving alpha 1-antitrypsin overexpression and consequent alpha-1 proteinase deficiency), the British hypothesis (regarding a ... ISBN 978-1-119-96373-8. Retrieved 15 November 2012. Hizawa, N (September 2009). "Genetic backgrounds of asthma and COPD". ...

https://en.wikipedia.org/wiki/Dutch_hypothesis

... and alpha-1 antitrypsin (the activity varies due to genetics or reaction of a critical methionine residue with toxins including ... 128 (1): 119-28. doi:10.1016/j.pharmthera.2010.06.003. PMC 7112678. PMID 20599443. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X ... 12 (1): 8. doi:10.1038/s41368-020-0074-x. PMC 7039956. PMID 32094336. Wikimedia Commons has media related to Pulmonary alveoli ... 2 (1): 33-46. doi:10.1186/rr36. PMC 59567. PMID 11686863. "Lung - Regeneration - Nonneoplastic Lesion Atlas". National ...

https://en.wikipedia.org/wiki/Pulmonary_alveolus

Acquired generalized lipodystrophy (Lawrence syndrome, Lawrence-Seip syndrome) Adiposis dolorosa (Dercum's disease) Alpha-1 ... antitrypsin deficiency panniculitis (alpha1-protease deficiency panniculitis, alpha1-proteinase deficiency panniculitis) ... alpha-N-acetylgalactosaminidase deficiency) Schinzel-Giedion syndrome Scleroatrophic syndrome of Huriez (Huriez syndrome, ... Familial alpha-lipoprotein deficiency (Tangier disease) Familial amyloid polyneuropathy Familial apoprotein CII deficiency ...

https://en.wikipedia.org/wiki/List_of_skin_conditions

Alpha 1-antitrypsin and alpha-2-macroglobulin are human serum protease inhibitors that completely inhibit the general ... Pancreatic elastase 1 is a serine endopeptidase, a specific type of protease that has the amino acid serine at its active site ... Elastase 1 is slightly inhibited above 150 mM NaCl Mutations of the CELA1 gene were suspected to be associated with diffuse ... 12 (1): 170-6. doi:10.1111/j.1432-1033.1970.tb00835.x. PMID 5461547. "CELA1 Gene". GeneCards. Davies RL, Yoon SJ, Weissenbach J ...

https://en.wikipedia.org/wiki/Pancreatic_elastase

In alpha 1-antitrypsin deficiency, the important neutrophil elastase is not adequately inhibited by alpha 1-antitrypsin, ... 451 (1): 1-10. doi:10.1016/S0014-2999(02)02182-9. PMID 12223222. Domon H, Nagai K, Maekawa T, Oda M, Yonezawa D, Takeda W, et ... 5 (1): 50-55. PMC 3272686. PMID 22328948. Basili S, Di Francoi M, Rosa A, Ferroni P, Diurni V, Scarpellini MG, Bertazzoni G ( ... 2 (1): 55-67. doi:10.1016/j.chom.2007.06.002. PMC 2083279. PMID 18005717. Kneller A (2007). "White blood cells are picky about ...

https://en.wikipedia.org/wiki/Neutrophil

... alpha-crystallin a chain MeSH D12.776.306.366.100.300 - alpha-crystallin b chain MeSH D12.776.306.366.300.100 - beta-crystallin ... steroid 12-alpha-hydroxylase MeSH D12.776.422.220.453.915.737 - steroid 16-alpha-hydroxylase MeSH D12.776.422.220.453.915.748 ... Retinoid X receptor alpha MeSH D12.776.826.701.500.625 - Retinoid X receptor beta MeSH D12.776.826.701.500.750 - Retinoid X ... alpha-macroglobulins See List of MeSH codes (D12.776.395). MeSH D12.776.402.150.100.200 - chimerin 1 MeSH D12.776.402.150. ...

https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D12.776)

... is a chemokine receptor. This name and the corresponding gene symbol IL8RA have been replaced by ... Interleukin 8 receptor, alpha has been shown to interact with GNAI2. Interleukin Interleukin 8 Interleukin 8 receptor, beta ... "Entrez Gene: IL8RA interleukin 8 receptor, alpha". Bergin DA, Reeves EP, Meleady P, Henry M, McElvaney OJ, Carroll TP, Condron ... Ahuja SK, Murphy PM (1996). "The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating ...

https://en.wikipedia.org/wiki/Interleukin_8_receptor,_alpha

... alpha-1 antitrypsin deficiency, glucose-6-phosphate dehydrogenase deficiency, early-onset of dystonia, factor XI deficiency, ... Retrieved May 1, 2019. "How 23andMe is Monetizing Your DNA". January 5, 2015. "Your DNA is a valuable asset, so why give it to ... Since October 1, 2020, the company has offered a new service called "23andMe+", priced at $29/year, for the customers of the " ... Ubelacker, Sheryl (October 1, 2014). "U.S. company launches genetic health and ancestry info service in Canada". Winnipeg Free ...

https://en.wikipedia.org/wiki/23andMe

... alpha 1 protein and causes skin fragility as well as weakness of the walls of arteries and internal organs. Marfan syndrome ... α1 antitrypsin deficiency and hereditary hemochromatosis, but evidence for these associations is weaker. Genetic studies in ... 1-2% of those with major trauma may have an injury to the carotid or vertebral arteries. In many cases of vertebral dissection ... 22 (1): 165-189. doi:10.1016/j.berh.2007.12.005. PMID 18328988. Debette S, Markus HS (June 2009). "The genetics of cervical ...

https://en.wikipedia.org/wiki/Vertebral_artery_dissection

α1-antitrypsin Alpha 1-antichymotrypsin Orosomucoid (acid glycoprotein) Serum amyloid A Alpha 1-lipoprotein Haptoglobin Alpha- ... The alpha globulins typically have molecular weights of around 93 kDa. Alpha globulins include certain hormones, proteins that ... Alpha 2-antiplasmin Protein C Alpha 2-lipoprotein Angiotensinogen Cortisol binding globulin Vitamin D-binding protein Alpha- ... Alpha globulins are a group of globular proteins in plasma that are highly mobile in alkaline or electrically charged solutions ...

https://en.wikipedia.org/wiki/Alpha_globulin

... alpha-macroglobulins MeSH D12.776.124.790.720.100.500 - pregnancy-associated alpha 2-macroglobulins The list continues at List ... immunoglobulin alpha-chains MeSH D12.776.124.486.485.114.619.251 - immunoglobulin d MeSH D12.776.124.486.485.114.619.251.500 - ... immunoglobulin alpha-chains MeSH D12.776.124.790.651.114.619.251 - immunoglobulin d MeSH D12.776.124.790.651.114.619.251.500 - ... immunoglobulin alpha-chains MeSH D12.776.124.486.485.705.500.360 - immunoglobulin delta-chains MeSH D12.776.124.486.485.705. ...

https://en.wikipedia.org/wiki/List_of_MeSH_codes_(D12.776.124)

The hereditary conditions - Marfan syndrome, homocystinuria, Ehlers-Danlos syndromes, alpha 1-antitrypsin deficiency (which ... 29 (1): 166. doi:10.1186/s13049-021-00976-1. PMC 8643006. PMID 34863280. Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, ... 43 (Suppl): 1-159. doi:10.1111/j.0954-6820.1932.tb05982.x. Tyson MD, Crandall WB (1941). "The surgical treatment of recurrent ... 22 (1): 8-16. doi:10.1136/emj.2003.010421. PMC 1726546. PMID 15611534. Lyra RD (May-June 2016). "Etiology of primary ...

https://en.wikipedia.org/wiki/Pneumothorax

M. Courtney, S. Jallat, L.H. Tessier, A. Benavente, R.G. Crystal and J.P. Lecocq Synthesis in E. coli of alpha1-antitrypsin ... Van Obberghen-Schilling cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization FEBS Lett ... Crystal Adenovirus-Mediated transfer of a recombinant alpha-1-antitrypsin gene to the lung epithelium in vivo Science, 252, 431 ... Lathe, Richard (1 January 1992). "Jean-Pierre Lecocq: A Personal Tribute". Gene. 118: 3-4. doi:10.1016/0378-1119(92)90241-g. ...

https://en.wikipedia.org/wiki/Jean-Pierre_Lecocq

Orosomucoid and antitrypsin migrate together but orosomucoid stains poorly so alpha 1 antitrypsin (AAT) constitutes most of the ... resulting in a typical elevation in the alpha-2 zone during inflammation. A normal alpha-2 and an elevated alpha-1 zone is a ... Alpha-2 macroglobulin may be elevated in children and the elderly. This is seen as a sharp front to the alpha-2 band. AMG is ... Stevenson, FT; Greene, S; Kaysen, GA (January 1998). "Serum alpha 2-macroglobulin and alpha 1-inhibitor 3 concentrations are ...

https://en.wikipedia.org/wiki/Serum_protein_electrophoresis

Tracy, born in 1990, was the first sheep to produce large quantities of human protein, making 35g of the alpha-1-antitrypsin ( ...

https://en.wikipedia.org/wiki/Anthony_John_Clark

... stain may show eosinophilic hyalin-like globules both inside and outside the cytoplasm that contain AFP and alpha 1-antitrypsin ...

https://en.wikipedia.org/wiki/Schiller–Duval_body

He named the blood plasma protein transferrin, and discovered that an inherited lack of Alpha 1-antitrypsin could lead to ... ISBN 91-1-863422-2. Retrieved 15 June 2022. v t e v t e (Articles with short description, Short description is different from ...

https://en.wikipedia.org/wiki/Carl-Bertil_Laurell

Cholesterol and glucose Alpha 1-antitrypsin Markers of inflammation and immune cell activation are typically elevated in ... Indian childhood cirrhosis is a form of neonatal cholestasis characterized by deposition of copper in the liver Alpha-1 ... antitrypsin deficiency is an autosomal co-dominant disorder of low levels of the enzyme alpha-1 antitrypsin Cardiac cirrhosis ... 1. Journal of the Association of Basic Medical Sciences. pp. 36-43. PMC 5596609. Naghavi M, Wang H, Lozano R, Davis A, Liang X ...

https://en.wikipedia.org/wiki/Cirrhosis

ER degradation-enhancing alpha-mannosidase-like 1 is an enzyme that in humans is encoded by the EDEM1 gene. GRCh38: Ensembl ... "EDEM accelerates ERAD by preventing aberrant dimer formation of misfolded alpha1-antitrypsin". Genes Cells. 11 (5): 465-76. doi ... "Entrez Gene: EDEM1 ER degradation enhancer, mannosidase alpha-like 1". Nagase T, Seki N, Ishikawa K, et al. (1997). "Prediction ... 2001). "A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation". EMBO Rep. 2 (5): 415-22. doi:10.1093/ ...

https://en.wikipedia.org/wiki/EDEM1

Alpha-1 antitrypsin deficiency is an inherited disorder that may cause lung disease and liver disease. Explore symptoms, ... Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of ... Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect. 2003 Dec; ... Alpha-1 antitrypsin deficiency is an inherited disorder that may cause lung disease and liver disease. The signs and symptoms ...

https://medlineplus.gov/genetics/condition/alpha-1-antitrypsin-deficiency/

Lomas work and told Medscape, "Weve learned more about COPD from studying alpha antitrypsin than people have learned from ... Alpha-1 antitrypsin is the most abundant circulating protease inhibitor in the body, Dr. Lomas said. Its most common deficiency ... Genetic analysis shows that antitrypsin deficiency appeared only about 2000 years ago in Northern Germany and was transferred ... September 21, 2007 (Stockholm) -- Basic research into the molecular biology of alpha-1 antitrypsin deficiency (AATD) and its ...

http://www.medscape.com/viewarticle/563206

Our lab offers gene sequencing to diagnose conditions like alpha-1-antitrypsin deficiency secondary to SERPINA1 mutations. ... Alpha-1-antitrypsin deficiency secondary to SERPINA1 mutations. Description. Variants in SERPINA1 are associated with alpha-1- ... Clinically significant alpha-1-antitrypsin deficiency is typically the result of homozygosity for the PI*Z allele or compound ... antitrypsin (A1AT) deficiency, which is inherited as an autosomal recessive condition. A1AT deficiency is one of the most ...

https://www.cincinnatichildrens.org/service/h/hereditary-liver/tests/alpha-1-antitrypsin

Louis University, have demonstrated that oxidative stress occurs in a genetic model of alpha-1-antitrypsin deficiency. ... Tags: Alpha-1 Antitrypsin Deficiency, Animal Model, Antioxidant, Carcinoma, Children, Cirrhosis, Enzyme, Fibrosis, Gene, Gene ... We have evidence of oxidative stress in livers from an animal model that expresses the classical Z variant form of alpha-1- ... antitrypsin. The animal model recapitulates the human liver disease, in which the livers accumulate polymers of alpha-1- ...

https://www.news-medical.net/news/20121030/Oxidative-stress-occurs-in-genetic-models-of-alpha-1-antitrypsin-deficiency.aspx

Find out about treatment and research for alpha 1-antitrypsin deficiency at UC San Diego Healths Advanced Lung Program. ... The most common abnormal genes are called S and Z. Normal genes are called M. A person who does not have Alpha-1 will have two ... The alpha 1-antitrypsin deficiency program at the UC San Diego Health is certified by the Alpha-1 Foundation. This distinction ... What is Alpha 1-antitrypsin Deficiency?. Alpha-1 antitrypsin (AAT) deficiency is a relatively common genetic condition that is ...

https://health.ucsd.edu/specialties/pulmonary/advanced-lung-disease/Pages/alpha1-deficiency.aspx

Alpha-1-Antitrypsin, Feces, 24 Hour (30523 ...

https://www.rchsd.org/lab-test/alpha-1-antitrypsin-feces-24-hour-30523/

History Of Patients With Alpha-1 Antitrypsin (EARCO). The safety and scientific validity of this study is the responsibility of ... Alpha 1-Antitrypsin Deficiency. Liver Diseases. Digestive System Diseases. Lung Diseases. Respiratory Tract Diseases. Genetic ... The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 ... European Alpha-1 Research Collaboration (EARCO) is a pan-European network committed to promoting clinical research and ...

https://www.clinicaltrials.gov/show/NCT04180319

Alpha-1 antitrypsin (A1AT) functions primarily to inhibit neutrophil elastase, and deficiency predisposes individuals to the ... results from small studies provide estimates of 1% to 5%. The present document updates a previous Canadian Thoracic Society ... forced expiratory volume in 1 s of 25% to 80% predicted) attributable to emphysema and documented A1AT deficiency (level ≤11 ... Alpha-1 antitrypsin (A1AT) functions primarily to inhibit neutrophil elastase, and deficiency predisposes individuals to the ...

https://www.hindawi.com/journals/crj/2012/920918/

The national alpha-1 antitrypsin deficiency registry in Poland. Joanna Chorostowska-Wynimko, Radoslaw Struniawski, Emil Wojda, ... The national alpha-1 antitrypsin deficiency registry in Poland. Joanna Chorostowska-Wynimko, Radoslaw Struniawski, Emil Wojda, ... The national alpha-1 antitrypsin deficiency registry in Poland. Joanna Chorostowska-Wynimko, Radoslaw Struniawski, Emil Wojda, ... The national alpha-1 antitrypsin deficiency registry in Poland Message Subject (Your Name) has sent you a message from European ...

https://erj.ersjournals.com/content/46/suppl_59/PA645

Alpha-1 antitrypsin is one of the protein synthesised in the liver and travels through the blood protecting the organs of the ... The global alpha-1 antitrypsin deficiency treatment market size expected to drive significant growth by 2026. ... Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market Size, Share and Global Trend By Drug Class (Alpha-1 proteinase inhibitor ...

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf-pop/alpha-1-antitrypsin-deficiency-aatd-treatment-market-100189

... Subscriber Sign In Feedback Select Language Share Search for a symptom, medication, or ... Alpha-1 antitrypsin deficiency in Adult. Print Images (5) Contributors: Holly Berg, Jennifer J. Findeis-Hosey MD. Other ... E88.01 - Alpha-1 Antitrypsin Deficiency. SNOMEDCT:. 30188007 - Alpha-1 Antitrypsin Deficiency. Look For. Subscription Required ... Alpha-1 antitrypsin deficiency (AATD) is a congenital disorder that primarily affects the lungs and liver. It is characterized ...

https://logicalimages.com/visualdx/diagnosis/alpha-1+antitrypsin+deficiency?moduleId=101&diagnosisId=50439

How familiar are you with the presentation and diagnosis of alpha-1 antitrypsin deficiency? Test your knowledge with this quick ... Alpha-1 antitrypsin deficiency (AATD) is a relatively common but frequently underrecognized disorder. It is considered the most ... Fast Five Quiz: Presentation and Diagnosis of Alpha-1 Antitrypsin Deficiency * Fast Five Quiz: Aromatic L-Amino Acid ... It is associated with various clinical manifestations, mainly characterized by reduced serum levels of alpha-1 antitrypsin as ...

http://reference.medscape.com/viewarticle/961436

Alpha-1 Canada is INSPIRED by this story! www.ctvnews.ca/health/national… The World Health Organization (WHO), American Th… ... Alpha-1 Canadas mission is to advocate for Canadians affected by Alpha-1 Antitrypsin Deficiency and to provide education to ... Alpha-1 Canada ne peut faire campagne pour obtenir une couverture de traitement bénéficiant aux Alphas canadiens sans votre ... Alpha-1 Canada travaille ardemment pour augmenter le dépistage et lémission de diagnostic pour le déficit en alpha-1 ...

https://alpha1canada.ca/fr/sabonner/

How familiar are you with the presentation and diagnosis of alpha-1 antitrypsin deficiency? Test your knowledge with this quick ... Fast Five Quiz: Presentation and Diagnosis of Alpha-1 Antitrypsin Deficiency * Fast Five Quiz: How Much Do You Know About COPD? ... Of note, alpha-1 antitrypsin replacement therapy should not be initiated without such testing. ... Fast Five Quiz: Presentation and Diagnosis of Alpha-1 Antitrypsin Deficiency - Medscape - Nov 23, 2021. ...

https://reference.medscape.com/viewarticle/961436_6

Alpha 1 Antitrypsin Deficiency Treatment Market was valued at $1.4 Bn in 2018 and is projected to grow at a CAGR of 9.41% to ... Global Alpha 1 Antitrypsin Deficiency Treatment Market, By Geography. • North America. o U.S.. o Canada. o Mexico. • Europe. o ... HomePharma & HealthcarePharmaceuticalGlobal Alpha 1 Antitrypsin Deficiency Treatment Market By Product, By Application, By ... Global Alpha 1 Antitrypsin Deficiency Treatment Market By Product, By Application, By Geography Scope And Forecast. Report ID: ...

https://www.verifiedmarketresearch.com/product/alpha-1-antitrypsin-deficiency-treatment-market/

Human alpha-1 antitrypsin (AAT) is an abundant serum protein, present at a concentration of 1.0-1.5 g L−1. AAT deficiency is a ... Human alpha-1 antitrypsin (AAT) is an abundant serum protein present at a concentration of 1.0-1.5 g L ... Human alpha-1 antitrypsin (AAT) is an abundant serum protein, present at a concentration of 1.0-1.5 g L−1. AAT deficiency is a ... Alpha-1 antitrypsin (AAT) deficiency is an inherited disorder that causes low levels of, or no AAT in the blood. The most ...

https://www.researchgate.net/publication/269988080_NiII_ions_cleave_and_inactivate_human_alpha-1_antitrypsin_hydrolytically_implicating_nickel_exposure_as_a_contributing_factor_in_pathologies_related_to_antitrypsin_deficiency

serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 16 ...

http://www.informatics.jax.org/marker/MGI:2684892

1 / ...

https://archbronconeumol.org/es-pdf-S1579212920300094

Alpha 1-Antitrypsin) ELISA Kit from Gentaur Elisa Kits. Cat Number: G-EC-04869. USA, UK & Europe Distribution. ... Mouse α1-AT (Alpha 1-Antitrypsin) ELISA Kit , G-EC-04869. Rating * Select Rating. 1 star (worst). 2 stars. 3 stars (average). 4 ... Mouse α1-AT (Alpha 1-Antitrypsin) ELISA Kit , G-EC-04869. Gentaur Elisa ... Mouse α1-AT (Alpha 1-Antitrypsin) ELISA Kit , G-EC-04869 , Gentaur Elisa Kits ...

https://caslab.com/mouse-1-at-alpha-1-antitrypsin-elisa-kit-g-ec-04869/?setCurrencyId=1

Welcome to the Pathology Education Informational Resource (PEIR) Digital Library, a multidisciplinary public access image database for use in medical education. ...

https://peir.path.uab.edu/library/index.php?/tags/4-gross/1854-alpha_1_antitrypsin_deficiency

Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β ... Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β ...

https://ard.bmj.com/content/75/6/1219.responses

BACKGROUND: Severe alpha 1-antitrypsin (AAT) deficiency (PiZZ) is associated with an increased risk of lung emphysema, ... BACKGROUND: Severe alpha 1-antitrypsin (AAT) deficiency (PiZZ) is associated with an increased risk of lung emphysema, ... Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1- ... antitrypsin deficiency (PiZZ). *Mark. Piitulainen, Eeva LU ; Tornling, Göran and Eriksson, Sten LU (1997) In Thorax 52(3). p. ...

https://lup.lub.lu.se/search/publication/1112222

The mean alpha-1 antitrypsin levels were in normal range for both the population with diffuse cystic lung pattern population ( ... Alpha-1 antitrypsin levels showed no correlation with lung function parameters or extent of cystic lesions on lung computed ... The aim of this study was to determine if there was an increase in alpha-1 antitrypsin deficient alleles or phenotypes in a ... demonstrating no increased incidence of alpha-1 antitrypsin deficiency in PLCH. ...

https://ojrd.biomedcentral.com/articles/10.1186/s13023-021-01720-9/tables/1

... News Published: June 10, 2010 ... "Omni Bio Announces FDA IND Clearance for Alpha-1 Antitrypsin Type 1 Diabetes Clinical Trial" ... to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in Type I diabetics.. Dr. Charles A. Dinarello, ... The decision to pursue a clinical trial of AAT in Type 1 diabetics was based on promising animal study data.. Dr. Dinarello ...

https://www.technologynetworks.com/drug-discovery/news/omni-bio-announces-fda-ind-clearance-for-alpha1-antitrypsin-type-1-diabetes-clinical-trial-204221

AAT is one of the most common genetic disorders in the Caucasian and Hispanic populations in the U.S., affecting 1 in 5,000 ... This November is Alpha-1 Antitrypsin (AAT) awareness month. Throughout the United States, United Kingdom, Australia and Canada ...

https://www.coopergenomics.com/disease-awareness/november-marks-awareness-initiatives-for-alpha-1-antitrypsin-deficiency/

Alpha-1-antitrypsin (A1AT) deficiency disease results from mutations in the A1AT gene. Controversy exists in regards to ... Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha (1)-antitrypsin deficiency: phenotypes and genetic modifiers of ... Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin ... Donato, L.J., Karras, R.M., Katzmann, J.A. et al. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous ...

https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-015-0256-9

Heterozygosity for α1‐antitrypsin (AAT) mutations is a cofactor of liver damage, and AAT influences inflammation and iron ... Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease.. *B ... Heterozygous α1-Antitrypsin phenotypes in patients with end stage liver disease. *M. Eigenbrodt, T. Mccashland, R. Dy, J. Clark ... Liver disease in adults with α1-antitrypsin deficiency. *M. Mandorfer, T. Bucsics, +9 authors. T. Reiberger ...

https://www.semanticscholar.org/paper/%CE%B11%E2%80%90Antitrypsin-mutations-in-NAFLD%3A-High-prevalence-Valenti-Dongiovanni/8dc21b982d849bbad117bf3b36fbc92fa187a431

What is Alpha-1 Antitrypsin? Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides ... Alpha-1 antitrypsin is an important protein which everyone has in their blood. It is produced by the liver, released into the ... The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by ... What is Alpha-1 Antitrypsin Deficiency? Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic ...

https://alpha1.ie/tag/alpha-1-antitrypsin/

https://reference.staging.medscape.com/viewarticle/961436

Alpha-1-antitrypsin in pulmonary tuberculosis. Journal of the Association of Physicians of India. 1984 Sep; 32(9): 807-8. en_US ...

https://imsear.searo.who.int/handle/123456789/86067?mode=full

September 21, 2007 (Stockholm) -- Basic research into the molecular biology of alpha-1 antitrypsin deficiency (AATD) and its role in both emphysema and its precursor, chronic obstructive pulmonary disease (COPD), has led to identification of novel compounds that are effective against fundamental disease processes in cell lines, according to a presentation here at the European Respiratory Society 17th Annual Congress. (medscape.com)
European Alpha-1 Research Collaboration (EARCO) is a pan-European network committed to promoting clinical research and education in alpha-1 antitrypsin deficiency (AATD). (clinicaltrials.gov)
EARCO has a global vision to increase the early diagnosis of alpha-1 antitrypsin deficiency (AATD), understand better the natural history of the disease and ensure optimal access to effective care, placing emphasis on ambitions that serve collective needs of the AATD research community and bringing people with AAT deficiency to the centre of the research environment in a real-world context. (clinicaltrials.gov)
Alpha-1 antitrypsin deficiency (AATD) is a relatively common but frequently underrecognized disorder. (medscape.com)
The alpha-1 antitrypsin deficiency (AATD) targeted screening programme alongside with the national registry have been established in Poland as late as 2010. (ersjournals.com)
  Pulmonary Disease Alpha-1 antitrypsin deficiency (AATD) is a congenital disorder that primarily affects the lungs and liver. (logicalimages.com)
BOSTON-(BUSINESS WIRE)- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the advancement of its investigational program targeting alpha-1 antitrypsin deficiency (AATD), a rare, genetic disease characterized by a protein folding defect that can lead to liver and lung disease. (novumpr.nl)
Measuring alpha-1 antitrypsin (AAT) serum levels is often the first step when investigating for alpha-1 antitrypsin deficiency (AATD). (copdfoundation.org)
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder arising from mutation of the SERPINA1 gene. (irishthoracicsociety.com)
[ 1 ] Liver diseases such as cirrhosis and chronic hepatitis are the result of the abnormal accumulation of AAT within the hepatocytes and hepatoma, and emphysema due to loss of the proteolytic protection of the lung are the two major clinical presentations of AATD of the PiZZ type. (medscape.com)
Patients with AATD frequently develop dyspnea 20-30 years earlier (at age 30-45 y) than do smokers with emphysema and normal alpha1-antitrypsin levels. (medscape.com)
No single physical sign confirms a diagnosis of alpha1-antitrypsin deficiency (AATD) emphysema. (medscape.com)

Increasing improvement in the diagnosis of alpha1-antitrypsin deficiency is estimated to boost the growth of the market. (growthmarketreports.com)
Increasing demand for deficiency treatment, improving economic scenario, increasing awareness regarding alpha1-antitrypsin deficiency, surging investment for the development of advanced and technical products are some of the factors that can accelerate the growth. (growthmarketreports.com)
The initial symptoms of alpha1-antitrypsin deficiency include cough, sputum production, and wheezing. (medscape.com)

Living with Alpha-1 Antitrypsin Deficiency offers the most up-to-date and comprehensive information on this illness and includes first-hand experience from someone managing the disease. (kcurmultimedia.org)
Living with Alpha-1 Antitrypsin Deficiency also includes expert advice from doctors and researchers tackling the disease, with tips on recognizing symptoms and getting the most effective help possible. (kcurmultimedia.org)

Individuals with two copies of the Z allele (ZZ) in each cell have a high risk of developing lung disease (such as emphysema) and liver disease associated with alpha-1 antitrypsin deficiency. (medlineplus.gov)
Alpha-1 antitrypsin is a protein that protects us from enzymes that destroy the lungs (causing emphysema or bronchiectasis). (ucsd.edu)
Standard treatment requires therapy for the underlying condition (emphysema or bronchiectasis) along with weekly infusions of alpha-1 protein replacement therapy. (ucsd.edu)
The evidence also supports consideration of A1AT augmentation therapy in nonsmoking or exsmoking patients with COPD (forced expiratory volume in 1 s of 25% to 80% predicted) attributable to emphysema and documented A1AT deficiency (level ≤11 μmol/L) who are receiving optimal pharmacological and nonpharmacological therapies (including comprehensive case management and pulmonary rehabilitation) because of benefits in computed tomography scan lung density and mortality. (hindawi.com)
BACKGROUND: Severe alpha 1-antitrypsin (AAT) deficiency (PiZZ) is associated with an increased risk of lung emphysema, especially in smokers. (lu.se)
PROLASTIN ® -C LIQUID is an alpha 1 -proteinase inhibitor (human) (alpha 1 -PI) indicated for chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe hereditary deficiency of alpha 1 -PI (alpha 1 -antitrypsin deficiency). (prolastin.com)
The accumulation of and the consequent reduction in the serum levels of alpha-1 antitrypsin cause, respectively, liver and lung disease, the latter occurring mainly as early emphysema, predominantly in the lung bases. (scielo.br)

Specific medical advice will not be provided and Alpha-1 Canada urges you to consult with a qualified physician for diagnosis and for answers to your personal questions. (alpha1canada.ca)
The Alpha-1 Foundation Genetic Counseling Program provides free guidance on testing and diagnosis of alpha-1 for physicians and other healthcare professionals. (prolastin.com)
Offers patients information on alpha-1 and explains how genetic counselors can provide support and guidance regarding a diagnosis of alpha-1 and what that diagnosis can mean to family members. (prolastin.com)
If your healthcare professional then confirms a diagnosis of alpha-1 , treatment options may exist in addition to your COPD medications. (geneticcopdtest.com)
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. (geneticcopdtest.com)
Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. (geneticcopdtest.com)
Diagnosis involves detection of low serum levels of alpha-1 antitrypsin as well as phenotypic confirmation. (scielo.br)
Note: Subjects with COPD and a diagnosis of alpha-1 anti-trypsin deficiency must have a transient elastography indicating no evidence of significant liver fibrosis (i.e., >7 kPa) or cirrhosis (i.e., >11 kPa). (who.int)

Genetic analysis shows that antitrypsin deficiency appeared only about 2000 years ago in Northern Germany and was transferred from Scandinavia by the Vikings. (medscape.com)
A team of researchers under the direction of Dr. Jeffrey Teckman in the Department of Pediatrics at St. Louis University, have demonstrated that oxidative stress occurs in a genetic model of alpha-1-antitrypsin deficiency. (news-medical.net)
In clinical studies, liver disease from alpha-1-antitrypsin mutant Z protein has shown considerable variability in severity and progression, suggesting that as yet undescribed genetic modifiers may influence disease development. (news-medical.net)
Alpha-1 antitrypsin (AAT) deficiency is a relatively common genetic condition that is often under-recognized. (ucsd.edu)
Alpha-1 Canada's mission is to advocate for Canadians affected by Alpha-1 Antitrypsin Deficiency and to provide education to patients and the healthcare community to increase awareness and testing for this genetic disease. (alpha1canada.ca)
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. (alpha1.ie)
Alpha-1 antitrypsin deficiency or AAT deficiency, is a genetic disorder characterized by a lack of AAT protein in the body. (growthmarketreports.com)
Alpha-1 is a rare genetic condition that is passed down from your parents through your genes. (geneticcopdtest.com)
Order your FREE AlphaID Genetic COPD Screener today to find out if you are at risk for genetic COPD due to alpha-1. (geneticcopdtest.com)
Alpha-1 antitrypsin deficiency is a recently identified genetic disease that occurs almost as frequently as cystic fibrosis. (scielo.br)
Alpha-1 Antitrypsin deficiency (A1AD) is a rare genetic, incurable disease which causes the liver to not produce enough of a certain protein that protects and keeps the lungs functional. (kcurmultimedia.org)
The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. (cdc.gov)
A rare genetic condition called alpha-1 antitrypsin deficiency can also cause the disease-but it is rare. (medlineplus.gov)

Variants (also known as mutations) in the SERPINA1 gene cause alpha-1 antitrypsin deficiency. (medlineplus.gov)
At the moment national registry lists 55 patients with severe AAT deficiency or rare mutations, including 36 PiZZ subjects (65%), 9 FM (16.4%), 5 IM (9.1%), 3 SZ (5.5%), 1 MZbristol (0.2%) and 1 MX. (ersjournals.com)
Alpha-1-antitrypsin (A1AT) deficiency disease results from mutations in the A1AT gene. (biomedcentral.com)
Heterozygosity for α1‐antitrypsin (AAT) mutations is a cofactor of liver damage, and AAT influences inflammation and iron metabolism. (semanticscholar.org)
Deficiency Mutations of Alpha-1 Antitrypsin. (bvsalud.org)

The Alpha-1 antitrypsin Deficiency Treatment Market is expected to expand at a robust CAGR during the forecast period, between 2021 and 2028. (growthmarketreports.com)
The global Alpha 1 Antitrypsin Deficiency Treatment market size is expected to be worth around US$ 4,890.60 million by 2031 from US$ 1,868.50 million in 2021, growing at a CAGR of 10.09% during the forecast period 2021 to 2031. (marketresearch.biz)
Between October 12 and November 1 of 2021, four children under the age of six years presented to the emergency department of a large pediatric hospital in Alabama. (cdc.gov)

Variants in SERPINA1 are associated with alpha-1-antitrypsin (A1AT) deficiency, which is inherited as an autosomal recessive condition. (cincinnatichildrens.org)
Alpha-1 antitrypsin (A1AT) functions primarily to inhibit neutrophil elastase, and deficiency predisposes individuals to the development of chronic obstructive pulmonary disease (COPD). (hindawi.com)
Alpha-1-antitrypsin (A1AT) is a serine protease inhibitor that protects the lung from enzymatic damage [ 1 ]. (biomedcentral.com)
Traditionally, laboratory analysis of A1AT deficiency involves two steps: (1) immuno-quantitation of serum A1AT protein and (2) identification of the disease-associated A1AT alleles [ 9 - 12 ]. (biomedcentral.com)
To report a case of severe bilateral descemetoceles in a patient with alpha-1 antitrypsin (A1AT) deficiency during intensive care unit hospitalization. (omicsdi.org)

A deficiência de alfa-1 antitripsina é um distúrbio genético de descoberta recente e que ocorre com freqüência comparável à da fibrose cística. (scielo.br)
A alfa-1 antitripsina é produzida principalmente no fígado e atua como uma antiprotease. (scielo.br)
O acúmulo e a conseqüente redução dos níveis séricos de alfa-1 antitripsina determinam, respectivamente, doença hepática e pulmonar, sendo que esta se manifesta principalmente sob a forma de enfisema de aparecimento precoce, habitualmente com predomínio basal. (scielo.br)
O diagnóstico envolve a detecção de níveis séricos reduzidos de alfa-1 antitripsina e a confirmação fenotípica. (scielo.br)
Além do tratamento usual para doença pulmonar obstrutiva crônica, existe atualmente uma terapia específica com infusão de concentrados de alfa-1 antitripsina. (scielo.br)

It is associated with various clinical manifestations , mainly characterized by reduced serum levels of alpha-1 antitrypsin as well as an increased risk of developing lung and liver diseases at an early age. (medscape.com)

This gene provides instructions for making a protein called alpha-1 antitrypsin, which protects the body from a powerful enzyme called neutrophil elastase. (medlineplus.gov)
Neutrophil elastase is released from white blood cells to fight infection, but it can attack normal tissues (especially the lungs) if not tightly controlled by alpha-1 antitrypsin. (medlineplus.gov)
Variants in the SERPINA1 gene can lead to a shortage (deficiency) of alpha-1 antitrypsin or an abnormal form of the protein that cannot control neutrophil elastase. (medlineplus.gov)
Without enough functional alpha-1 antitrypsin, neutrophil elastase destroys alveoli and causes lung disease. (medlineplus.gov)

Alpha-1 antitrypsin deficiency is an inherited disorder that may cause lung disease and liver disease. (medlineplus.gov)
People with alpha-1 antitrypsin deficiency usually develop the first signs and symptoms of lung disease between ages 25 and 50. (medlineplus.gov)
About 10 percent of infants with alpha-1 antitrypsin deficiency develop liver disease, which often causes yellowing of the skin and whites of the eyes (jaundice). (medlineplus.gov)
Many individuals with alpha-1 antitrypsin deficiency are likely undiagnosed, particularly people with a lung condition called chronic obstructive pulmonary disease (COPD). (medlineplus.gov)
Clinically significant alpha-1-antitrypsin deficiency is typically the result of homozygosity for the PI*Z allele or compound heterozygosity for the PI *S*Z alleles, although other disease-causing alleles are identified in ~5% of affected individuals. (cincinnatichildrens.org)
The animal model recapitulates the human liver disease, in which the livers accumulate polymers of alpha-1-antitrypsin mutant Z protein, developing fibrosis and hepatocellular carcinoma with age', says Dr. Marcus. (news-medical.net)
The UC San Diego Health Advanced Lung Disease Program offers patients with alpha 1-antitrypsin deficiency both standard and cutting-edge investigational therapies. (ucsd.edu)
Despite the prevalence of Type 1 diabetes in the juvenile population, patients and their parents are still waiting for a solution that can stop this debilitating disease in its tracks. (technologynetworks.com)
Alpha 1 Antitrypsin deficiency is a rare disease causing numerous physical problems science cannot even detect. (themighty.com)
MDs say these coincidental problems are not caused by Alpha 1 but do they really know without the research to fully comprehend this disease. (themighty.com)
In addition to the standard treatment of chronic obstructive pulmonary disease, specific therapy consisting of infusion of purified alpha-1 antitrypsin is currently available. (scielo.br)
A knowledgeable handbook with a patient's perspective for those afflicted with the incurable disease known as Alpha-1 Antitrypsin deficiency (A1AD). (kcurmultimedia.org)
Alpha 1-Antitrypsin Deficiency And Fatty Liver Disease - Cure Your Fatty Liver Naturally (For Good! (terpsichoresand.org)
Alpha 1-Antitrypsin Deficiency And Fatty Liver Disease A fatty liver overview is crucial for those suffering from the disease. (terpsichoresand.org)
OBJECTIVE: The study aimed to examine whether alpha-1-antitrypsin (AAT), an inhibitor of leukocyte esterase(LE), which damages the venous vessel wall, has a protective effect against chronic venous disease(CVD), and to examine the relationship between AAT levels and disease severity. (nevinmanimala.com)
Clinical Etiologic Anatomic Pathologic (CEAP) classification was used to assess disease severity, and patients were divided into CEAP 1-5 groups accordingly. (nevinmanimala.com)
1 NTM disease. (cdc.gov)
in 7 of those households, the patient classic risk factors for NTM disease are also at risk for NTM isolate and 1 plumbing isolate exhibited the same repetitive pulmonary disease ( 11 - 13 ). (cdc.gov)

1 , 2 ) In 2020, residents of long-term care facilities made up less than 1% of the U.S. population but accounted for more than 35% of all COVID-19 deaths. (cdc.gov)

According Verified Market Research, Global Alpha 1 Antitrypsin Deficiency Treatment Market was valued at USD 1.4 Billion in 2018 and is projected to grow at a CAGR of 9.41% to reach USD 2.8 Billion by 2026 , over the forecast period. (verifiedmarketresearch.com)
The Global Alpha 1 Antitrypsin Deficiency Treatment Market report provides a holistic evaluation of the market for the forecast period (2017-2026). (verifiedmarketresearch.com)
The Global Alpha 1 Antitrypsin Deficiency Treatment Market study provides an outlook on the development of market in terms of revenue throughout the prognosis period. (verifiedmarketresearch.com)
This report provides an all-inclusive environment of the analysis for the Global Alpha 1 Antitrypsin Deficiency Treatment Market. (verifiedmarketresearch.com)
These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics affecting the Global Alpha 1 Antitrypsin Deficiency Treatment Market growth. (verifiedmarketresearch.com)
Along with the market overview, which comprises of the market dynamics the chapter includes a Porter's Five Forces analysis which explains the five forces: namely buyers bargaining power, suppliers bargaining power, threat of new entrants, threat of substitutes, and degree of competition in the Global Alpha 1 Antitrypsin Deficiency Treatment Market. (verifiedmarketresearch.com)
The report also focuses on the competitive landscape of the Global Alpha 1 Antitrypsin Deficiency Treatment Market. (verifiedmarketresearch.com)
The market analysis entails a section solely dedicated for major players in the Global Alpha 1 Antitrypsin Deficiency Treatment Market wherein our analysts provide an insight to the financial statements of all the major players along with its key developments product benchmarking and SWOT analysis. (verifiedmarketresearch.com)
Other sources include industry magazines, trade journals, government websites, and associations were can also be reviewed for gathering precise data on opportunities for business expansions in Global Alpha 1 Antitrypsin Deficiency Treatment Market. (verifiedmarketresearch.com)
The report on alpha-1 antitrypsin deficiency treatment market includes an assessment of the market, size, share, trends, segments, and regional markets. (growthmarketreports.com)
Based on route of administration, the alpha-1 antitrypsin deficiency treatment market can be segregated into parental, inhalation and oral. (growthmarketreports.com)
What Our Global Alpha 1 Antitrypsin Deficiency Treatment Market Report Offers? (marketresearch.biz)
Global Alpha 1 Antitrypsin Deficiency Treatment Market is the title of an upcoming report offered by MarketResearch.Biz. (marketresearch.biz)
The Alpha 1 Antitrypsin Deficiency Treatment market report extensively covers market segmentation by treatment type, by route of administration, by end-user, by geography (APAC, North America, Europe, South America, and MEA) and potential Alpha 1 Antitrypsin Deficiency Treatment market drivers that the vendors are capitalizing on to sustain profitable growth. (marketresearch.biz)
Furthermore, read about the latest key findings on the post-COVID-19 impact on the Alpha 1 Antitrypsin Deficiency Treatment market from this report. (marketresearch.biz)
It is complete with important statistics and other industry-relevant particulars, including factors expected to influence Alpha 1 Antitrypsin Deficiency Treatment market progress, drivers, restraints, opportunities, trends, sales reviews, landmark developments (existing and anticipated), SWOT analysis, as well as information on other potential revenue generation prospects in un explored areas of operation. (marketresearch.biz)
The global Alpha 1 Antitrypsin Deficiency Treatment market report will encompass imminent threats or challenges from existing industry contenders, as well as potential new market entrants. (marketresearch.biz)
The same applies to the global Alpha 1 Antitrypsin Deficiency Treatment market. (marketresearch.biz)
These aforementioned elements are expected to burden the revenue trajectory of the global Alpha 1 Antitrypsin Deficiency Treatment market over the forecast timeline. (marketresearch.biz)
However, as respective governing authorities begin to lift these enforced lockdowns, the global Alpha 1 Antitrypsin Deficiency Treatment market is expected to recover accordingly. (marketresearch.biz)
Who are the Major Alpha 1 Antitrypsin Deficiency Treatment Market's Key Players? (marketresearch.biz)

Alpha-1 antitrypsin is the most abundant circulating protease inhibitor in the body, Dr. Lomas said. (medscape.com)
PROLASTIN-C LIQUID ® (alpha 1 -proteinase inhibitor [human]) is ONLY available through the PROLASTIN DIRECT program. (prolastin.com)

Our clinical experts are actively involved in expanding horizons in the area of research for alpha 1-antitryspin deficiency. (ucsd.edu)
The study population will consist of individuals with diagnosed severe alpha-1 antitrypsin deficiency regardless of the clinical expression and severity. (clinicaltrials.gov)
Omni Bio Pharmaceutical, Inc.(OMNI), has announced that the Barbara Davis Center for Childhood Diabetes has received IND regulatory clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in Type I diabetics. (technologynetworks.com)
Dr. Charles A. Dinarello, Acting Chief Executive Officer of OMNI, stated, "We are pleased to announce IND Clearance for a Phase I/II clinical trial in Type 1 diabetics. (technologynetworks.com)
The decision to pursue a clinical trial of AAT in Type 1 diabetics was based on promising animal study data. (technologynetworks.com)

Environmental factors, such as exposure to tobacco smoke, chemicals, and dust, likely impact the severity of alpha-1 antitrypsin deficiency. (medlineplus.gov)

The mean FEV 1 /FVC ratio was 53 ± 21% (45 ± 20% in PiZZ group). (ersjournals.com)

The most common abnormal genes are called S and Z. Normal genes are called M. A person who does not have Alpha-1 will have two M genes (MM). Some people even with 2 abnormal genes have no symptoms and do not develop complications. (ucsd.edu)
Symptoms develop about 10 years earlier in alpha1-antitrypsin-deficient individuals who smoke regularly. (medscape.com)

In addition to medical care, patients will benefit from additional services provided to improve their health and empower them with the knowledge of alpha 1-antitrypsin deficiency. (ucsd.edu)
Alpha-1 Canada travaille ardemment pour augmenter le dépistage et l'émission de diagnostic pour le déficit en alpha-1 Antitrypsine et exercer des pressions afin de rendre l'accès aux traitements aux patients Alphas équitable partout au Canada. (alpha1canada.ca)
Alpha-1 Canada envoie parfois des communications électroniques aux personnes inscrites pour les informer de nouvelles opportunités d'essais cliniques, de groupes de discussion ou de réseautage, de rencontres ou d'autres événements basés sur la communauté des patients Alpha-1 et de leurs familles. (alpha1canada.ca)
La mission d'Alpha-1 Canada est de militer pour les canadiens qui souffrent d'un déficit en alpha 1-antitrypsine et d'offrir de la formation aux patients et à la communauté médicale afin d'augmenter la sensibilisation à cette maladie génétique et aux examens possibles. (alpha1canada.ca)
Grifols is committed to partnering with healthcare professionals, providing the alpha-1 healthcare community with the resources needed to make a difference in patients' lives. (prolastin.com)
If you would like further information on PROLASTIN-C LIQUID and how it helps treat patients with alpha-1 , please request to meet with a Grifols alpha-1 specialty representative in your area. (prolastin.com)
Provides patients recently diagnosed with alpha-1 a comprehensive look at what they need to know with regard to what alpha-1 is, available treatment options, and certain lifestyle changes they may need to make. (prolastin.com)
In keeping with this mission, AlphaNet provides a wide range of specialized programs and services designed to meet the specific needs of the patients with alpha-1 it serves. (prolastin.com)
The Alpha-1 Foundation is the only national organization dedicated to developing a cure for alpha-1 and to improving the quality of life for patients and their families. (prolastin.com)
Alpha-1 is underdiagnosed because it is often overshadowed by patients' smoking history. (geneticcopdtest.com)
33. Benkmann G, Hanssen P, Ovenbeck R, Goedde W. Distribution of alpha-1 antitrypsin and haptoglobin phenotypes in bladder cancer patients. (bvsalud.org)

Alpha-1 antitrypsin deficiency occurs worldwide, but its prevalence varies by population. (medlineplus.gov)
Steven R. Goodman, PhD, Editor-in-Chief of Experimental Biology and Medicine said, 'Teckman and colleagues have demonstrated that oxidative stress occurs in an animal model of Alpha-1-antitrypsin deficiency. (news-medical.net)

Severe bilateral descemetoceles in Alpha-1 antitrypsin deficiency. (omicsdi.org)

Guidelines from both the World Health Organization (WHO) and American Thoracic Society (ATS) recommend testing all people with COPD for alpha-1 , regardless of their age or smoking history. (geneticcopdtest.com)
For the treatment of MAC in the setting of bronchiectasis, the American Thoracic Society recommends a 3- to 4-drug treatment regimen with clarithromycin, rifampin, ethambutol, and possibly streptomycin that is continued until the patient's culture results are negative for 1 year. (medscape.com)

The most common version (allele) of the SERPINA1 gene, called M, produces normal levels of alpha-1 antitrypsin. (medlineplus.gov)
Other versions of the SERPINA1 gene lead to reduced levels of alpha-1 antitrypsin. (medlineplus.gov)

Abnormal alpha-1 antitrypsin can also accumulate in the liver and damage this organ. (medlineplus.gov)

Alpha-1-antitrypsin deficiency is a hereditary lung condition in which the lungs do not have the ability to defend themselves against diseases and pollutants. (hemarusplasma.us)

54(1): 71-80, 2016 Jan. (bvsalud.org)

Individuals with alpha-1 antitrypsin deficiency are also at risk of developing a type of liver cancer called hepatocellular carcinoma. (medlineplus.gov)
This disorder affects about 1 in 1,500 to 3,500 individuals with European ancestry. (medlineplus.gov)
Individuals with an MS (or SS) combination usually produce enough alpha-1 antitrypsin to protect the lungs. (medlineplus.gov)
This distinction recognizes our program's dedication to the care, advancement of research and treatments for individuals with Alpha-1 deficiency. (ucsd.edu)
AlphaNet has one mission-to improve the lives of individuals affected by alpha 1 -antitrypsin deficiency. (prolastin.com)

There are many types of abnormal alpha-1 antitrypsin genes. (ucsd.edu)

Alpha-1 Canada ne peut faire campagne pour obtenir une couverture de traitement bénéficiant aux Alphas canadiens sans votre soutien. (alpha1canada.ca)
Les nouveau-nés présentant une suspicion de septicémie néonatale traités dans un hôpital de la ville d'Al Ramadi (Iraq) en 2005 ont fait l'objet d'un dosage de la PCR sérique et d'hémocultures (méthode de référence) lors de l'admission puis 48 heures, 4 jours et enfin 6 jours après le début du traitement. (who.int)

An updated list of high-risk underlying conditions, based on what has been reported in the literature as of January 1, 2022 is provided below. (cdc.gov)

For example, the S allele produces moderately low levels of this protein, and the Z allele produces very little alpha-1 antitrypsin. (medlineplus.gov)
About 1 in 1700 whites of northern European descent are homozygotes for this mutation and thus have plasma antitrypsin levels that are 10% to 15% below normal, he said. (medscape.com)
It is characterized by low levels of the protein alpha-1 antitrypsin (AAT) in the blood. (logicalimages.com)
What Do Alpha-1 Antitrypsin Levels Tell Us About Chronic Inflammation in COPD? (archbronconeumol.org)
Having low levels of the alpha-1 protein can leave your lungs vulnerable to serious damage. (geneticcopdtest.com)
AAT levels were similar in the CEAP 1-3 group and decreased in the CEAP-4 group but increased again in the CEAP-5 group. (nevinmanimala.com)

La deficiencia hereditaria en A1P1 se asocia con ENFISEMA PULMONAR. (bvsalud.org)

Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. (alpha1.ie)

in 1% to 2% of breastfed babies, jaundice may be caused by substances produced in their mother's breast milk that can cause the bilirubin level to rise. (findmeacure.com)

Human alpha-1 antitrypsin (AAT) is an abundant serum protein, present at a concentration of 1.0-1.5 g L−1. (researchgate.net)

Only your healthcare professional can test for alpha-1. (geneticcopdtest.com)

In rare cases, people with alpha-1 antitrypsin deficiency develop a skin condition called panniculitis, which is characterized by hardened skin with painful lumps or patches. (medlineplus.gov)

Dr. Dinarello further stated, "If AAT's efficacy in humans is similar to that observed in our animal studies, it could become a method of treatment for qualifying Type 1 diabetics. (technologynetworks.com)
VX-634 is an investigational small molecule that promotes proper folding of Z-AAT protein and is being evaluated for the treatment of alpha-1 antitrypsin deficiency. (novumpr.nl)
Additionally, management of underlying conditions, which may include the use of intravenous immunoglobulin or intravenous alpha1-antitrypsin (AAT) therapy, is essential to the overall treatment. (medscape.com)

It is hoped that the creation of the Alpha One International Registry will resolve these and other important issues. (scielo.br)

Some people with alpha-1 antitrypsin deficiency are misdiagnosed with asthma. (medlineplus.gov)

The PlasmaTech SDF (salt diafiltration) process is a plasma-based platform was introduced for mass production of orphan protein therapeutics such as alpha-1 antitrypsin Thus, such innovation can create lucrative opportunities for the industry players. (growthmarketreports.com)
T. alpha-1-antitrypsin deficiency of true "orphan" diseases, e.g. (starkelunge.de)

It consists of 70 amino acid residues with a molecular mass of 7649 daltons.1 It is structurally homologous to IGF-II and insulin. (unitslab.com)

[ 1 ] Urine osmolality is greater than plasma osmolality. (medscape.com)

Of note, alpha-1 antitrypsin replacement therapy should not be initiated without such testing. (medscape.com)
1 April 2005 to 1 December 2005 at the reveal that empirical therapy results in treat- neonatal care unit of the maternity and chil- ment of as many as 30 un infected infants dren's hospital in Ramadi city, Iraq. (who.int)

Anatomy2

Organisms1

Diseases5

Chemicals and Drugs42

Analytical, Diagnostic and Therapeutic Techniques and Equipment6

Phenomena and Processes14

Information Science3

The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. (1/1525)

Identification of DNA polymorphisms associated with the V type alpha1-antitrypsin gene. (2/1525)

The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. (3/1525)

Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. (4/1525)

Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. (5/1525)

Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. (6/1525)

Probing the unfolding pathway of alpha1-antitrypsin. (7/1525)

A kinetic mechanism for the polymerization of alpha1-antitrypsin. (8/1525)

alpha 1-Antitrypsin

alpha 1-Antitrypsin Deficiency

Pulmonary Emphysema

Pancreatic Elastase

alpha 1-Antichymotrypsin

Emphysema

Trypsin Inhibitors

Leukocyte Elastase

Receptors, Adrenergic, alpha

Hypoxia-Inducible Factor 1, alpha Subunit

Serpins

Serine Proteinase Inhibitors

Phenotype

Base Sequence

alpha7 Nicotinic Acetylcholine Receptor

Molecular Sequence Data

Isoelectric Focusing

Liver

Integrin alpha3beta1

Integrin alpha4

Integrin alpha6

Mutation

Recombinant Proteins

Integrin alpha5beta1

Orosomucoid

Protein Binding

Integrin alpha4beta1

Interleukin-1alpha

Electrophoresis, Polyacrylamide Gel

Liver Diseases

Kinetics

Integrin alpha2beta1

Binding Sites

Hepatocyte Nuclear Factor 1-alpha

Amino Acid Sequence

Receptors, Adrenergic, alpha-1

Haptoglobins

Protein Conformation

Integrin alpha5

Integrin alpha1beta1

Receptors, Adrenergic, alpha-2

Chymotrypsin

Integrin alpha6beta1

Protein-Losing Enteropathies

Macroglobulins

Gene Expression Regulation

Transfection

Integrin alpha6beta4

Integrin alpha Chains

Endoplasmic Reticulum

Integrins

Albumins

Blood Proteins

Integrin alpha1

DNA

alpha-Macroglobulins

Trypsin

Heterozygote

Homozygote

Alpha Rhythm

Protein C Inhibitor

Models, Molecular

Proprotein Convertase 5

Cloning, Molecular

Pancreatin

Integrin alpha3

Furin

Alleles

Mice, Inbred C57BL

The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. (1/1525)

Identification of DNA polymorphisms associated with the V type alpha1-antitrypsin gene. (2/1525)

The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. (3/1525)

Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. (4/1525)

Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. (5/1525)

Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. (6/1525)

Probing the unfolding pathway of alpha1-antitrypsin. (7/1525)

A kinetic mechanism for the polymerization of alpha1-antitrypsin. (8/1525)

Development of Novel Therapies for Liver Disease Associated with Misfolded Z Alpha-1-Antitrypsin Accumulation and Disposal

Hemorrhagic Disease Due to Alpha-1-Antitrypsin Pittsburgh Mutation: Symptoms, Diagnosis and Treatment - Symptoma

Association of polymorphism of the alpha 1-antitrypsin gene with milk production traits in Chinese Holstein

$Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic...$ Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic...

$Gentaur Molecular :Alpha Dia \ Anti Human Alpha 1 Antitrypsin IgG, HRP conjugate \ A1AT11-HRP$ Gentaur Molecular :Alpha Dia \ Anti Human Alpha 1 Antitrypsin IgG, HRP conjugate \ A1AT11-HRP

$Gentaur Molecular :Molecular Innovations \ Alpha 1 Antitrypsin, Human Plasma \ HA1AT$ Gentaur Molecular :Molecular Innovations \ Alpha 1 Antitrypsin, Human Plasma \ HA1AT